Health & Biotech ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals July 4, 2022 ASX health stocks HitIQ and Volpara have signed major deals in the US, showing that Australian technologies are world class. EZZ’s cashes in on China’s multi-billion dollar e-commerce shopping festival with one product proving a winner July 4, 2022 Special Report: EZZ’s Bone Growth Capsules have proven a winner at one of China’s biggest e-commerce festivals of the year… Dr Boreham’s Crucible: Will the FDA bend the knee after Paradigm’s Phase III tests? July 4, 2022 Paradigm Biopharmaceuticals’ (ASX:PAR) investment relations guy Simon White is a bit different to your average biotech corporate gun for hire,… ScoPo’s Powerplays: ASX health stocks show signs of jittery recovery July 1, 2022 ASX Health stocks slightly up but feel continued pressure of market volatility and June being a traditional tax-loss selling month. Wellnex delivers full year revenue lift despite global supply chain glut, says FY23 revenue will now jump by 50% July 1, 2022 Special Report: Aussie health and wellness company Wellnex Life Limited (ASX: WNX) says unaudited revenue jumped by almost 7% on… Neurotech tackles the anguish of autism with low-THC cannabis treatment July 1, 2022 Special Report: A medical dilemma in its own right - the modern treatment of the condition commonly known as ‘autism’… Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence July 1, 2022 Retail and independent cannabis lounges could be opening soon in Vegas and Cann Group gets good manufacturing practice (GMP) licence. Medlab Clinical heads for Nasdaq listing and land of opportunity June 30, 2022 Special Report: Medlab clinical has laid out its road map to a dual listing on the Nasdaq to help open… Osteopore hard at work on the next generation of its 3D-printed bioresorbable implants with focus on the large orthopaedic market June 30, 2022 Special Report: Osteopore is working on the next generation of its ground-breaking implants which will capture up to 40-50% of… ASX Health Stocks: Cann’s Mildura cannabis facility gets GMP licence, unlocking export markets June 30, 2022 Cannabis company Cann Group rose 17% this morning after being granted a Good Manufacturing Practice licence to manufacture therapeutic goods. Next» « Previous